Johnson & Johnson Ordered to Pay $40 Million to 2 Women
Antara Bhattacharyya
A US jury ordered Johnson & Johnson to pay $40 million after finding product-linked cancer risks affecting two women plaintiffs.
The lawsuit claimed long-term use of company products caused serious health complications, including cancer diagnoses, according to court findings records.
Jurors reportedly agreed evidence showed negligence and inadequate warnings, reinforcing growing scrutiny over corporate accountability in consumer safety cases nationwide.
Johnson & Johnson denied wrongdoing and stated it plans to appeal, maintaining that product safety standards remain scientifically supported globally today.
The verdict could influence future lawsuits, investor sentiment, and regulatory oversight of pharmaceutical and consumer healthcare companies worldwide.